Oxford Biodynamics
高管
查看带有其 12 名主要高管的组织结构图
Oxford Biodynamics 搜索最多的简介
- Jon Burrows, Chief Executive Officer and Director
- David Holbrook, Independent Non-Executive Director
- Matthew Wakefield, Non-Executive Chairman of the Board
创建提醒
跟踪 Oxford Biodynamics 的高管变动
生物技术
Oxford Biodynamics 拥有 2,327 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。
Popular M&A news in 生物技术
- Chromocell的新名称是Channel Therapeutics Corporation。 (公布2024十一月22号).
- Enveda Biosciences 刚刚宣布为 130 筹款数百万美元。 (公布2024十一月22号).
- Alentis Therapeutics 刚刚宣布为 181 筹款数百万美元。 (公布2024十一月20号).
生物技术 行业的其他推荐联系人
消息
Oxford Biodynamics 的最新新闻稿
- In The News
- Oxford BioDynamics part of consortium shortlisted for Strategic Government Initiative to Improve Cancer Immunotherapy
- New Blood Test for Prostate Cancer Claims 94% Accuracy
- Bupa UK to cover EpiSwitch® CiRT for customers
- In The News
- OBD Prostate Screening EpiSwitch Blood Test Update
- New prostate cancer test is 94% accurate, researchers say | ITV News
- Scientists create ‘impressive’ new blood test for prostate cancer with 94% accuracy
- New prostate cancer test could spare men from needless biopsies
- Advancing cancer care with 3D genomics
- View more press releases Close
通过电子邮件
